Production of short-chain fatty acids (SCFAs), especially butyrate, in the gut microbiome is 19 required for optimal health but is frequently limited by the lack of fermentable fiber in the diet. 20
INTRODUCTION 37
Short-chain fatty acids (SCFAs) are major end products of bacterial fermentation in the human 38 colon and are known to have wide-ranging impacts on host physiology. Butyrate in particular is 39 important for maintaining health via regulation of the immune system (1), maintenance of the 40 epithelial barrier (2, 3) , and promoting satiety following meals (4). It may be protective against 41 several diseases, including colorectal cancer (5), inflammatory bowel disease (6), graft-versus-host 42 disease (7), diabetes (8), and obesity (8, 9) . Therefore, stimulating butyrate production by the 43 colonic microbiome could be useful for sustaining health and treating diseases. 44 45 One strategy for stimulating butyrate production is to supplement the diet with carbohydrates 46 that are resistant to degradation by human enzymes but can be metabolized by select bacteria in 47 the colon. We previously demonstrated that one such resistant starch (RS) prepared from 48 potatoes (RPS) could increase average fecal butyrate in healthy, young adults (10). Others have 49 reported increased butyrate in response to inulin in humans and resistant starch from maize (RMS) 50 in mice (11, 12) . A critical challenge to these potential therapies is the variable responses between 51 individuals, likely influenced by differences in the composition of their gut microbiota. To capture 52 this variability large numbers of subjects are required. We analyzed samples from 174 university 53 students who consented to participate in and then successfully completed this short-term 54 interventional study. This young cohort provided a wide diversity of gut communities without the 55 additional complications of chronic health conditions such as obesity, Type 2 diabetes or 56 cardiovascular disease that are related to altered microbiome structure and function (13, 14) . We 57 did not ask the participants to make changes to their diets other than taking the supplements 58 provided, even though we recognize different diets also have a profound impact on microbiome 59 Page 4 of 31 structure and function. Our objective was to determine how these different resistant 60 polysaccharides affected the concentrations of SCFAs when added to "normal" diets, not just 61 under one dietary regimen. With this number of participants we were able to evaluate three 62 different resistant polysaccharides and an amylase-sensitive polysaccharide as a negative control. 63 64 Understanding the butyrogenic effect of these supplements and specific gut bacteria is important 65 for designing more broadly effective therapies and predicting which individuals are likely to 66 benefit from them. More generally, defining metabolic interactions among gut microbes enhances 67 our understanding of the assembly, maintenance and outputs from the gut microbiome. 68 69 Identifying butyrogenic configurations of the microbiome is challenging because several different 70 bacteria (or combinations of bacteria) may be involved in the multi-step process. Many bacteria in 71 the colon are involved in the degradation of dietary fiber, the complex mixture of plant 72 polysaccharides that is not susceptible to host enzymes (15, 16) . However, many of these bacteria 73 are specialists, attacking specific bonds in specific types of polymers (17) (18) (19) . Only a limited 74 number of gut bacteria may be able to degrade any given resistant polysaccharide that is used as a 75 dietary supplement. Primary degraders depolymerize specific polysaccharides to mono-, di-and 76 oligo-saccharides that they can take-up and ferment themselves to acidic end products such as 77 acetate or lactate (20). Their selective growth on the dietary supplement should result in a higher 78 relative abundance in fecal communities. However, most resistant starch degraders are not 79 among known butyrate producers (19, 21). Thus, for these supplements to stimulate butyrate 80 production, the activities of additional organisms would be required. These secondary fermenters 81 capture degradation and fermentation products from primary degraders and metabolize them into 82
Page 5 of 31 new molecules including butyrate ( Fig. 1 ). However, if primary degraders use the supplements 83 efficiently, only a fraction of the carbon and energy they contain may become available to the 84 secondary fermenters. Therefore, increases in the relative abundance of butyrate producers may 85 be more difficult to detect, but their metabolic activity could still be evidenced by an increase in 86 fecal butyrate. 87 88 Candidates for performing one or more of the steps in Fig. 1 These known degraders and butyrate producers were targeted for evaluation in this dietary 112 intervention. But we also analyzed the entire community of fecal bacteria to identify any 113 organisms that had not previously been associated with the metabolism of these fermentable 114 fibers. We attempted to address four major issues: 115 1. Do the three resistant polysaccharides stimulate butyrate production in this population of 116 healthy, young individuals? If so, do they have similar impacts on butyrate production? 117 2. Which gut bacteria respond to these dietary additions by increasing in relative abundance? 118
Can we identify any species that were unexpectedly affected? Are the same bacteria affected 119 by all three supplements? 120 3. Can we find any evidence of selectivity, either in the substrates used by primary degraders or 121 in the butyrate producers they cross feed? 
Effects on Short Chain Fatty Acids 127
We first examined the impact of each supplement on the concentration of SCFAs in the feces. Both 128 RPS and inulin significantly increased total SCFA concentrations, by 32% and 12% respectively 129 (both p<0.001). Supplementation with RPS increased butyrate concentrations by an average of 130 29% (p<0.001) and acetate by an average of 21% (p=0.0012, Table 1 ). However, the response was 131 highly variable between individuals: the median concentration of butyrate increased in 63% of 132 individuals and was either unchanged or decreased in the remaining 37%. Although total SCFA 133 concentrations increased with inulin supplementation, there were no statistically significant 134 changes in individual SCFAs. Nor were there significant changes in the concentration of any of the 135 SCFAs in the groups whose diet was supplemented with either RMS or accessible starch (Table 1) . 136
Furthermore, there were no significant differences in SCFA concentrations between the control 137 group that consumed 20 g of accessible starch compared to the group that consumed 40 g of 138 accessible starch. 139 140
Effects on Bacterial Communities 141
We characterized changes to the gut microbiota using 16S rRNA gene sequencing. We chose not to 142 cluster sequences into operational taxonomic units (OTUs) after discovering that several taxa of 143 interest, with very different responses to the dietary supplements, would be clustered into a single 144 OTU even at 99% identity. For example, Bifidobacterium longum and B. faecale have varying 145 abilities to degrade RS, but the V4 region of the 16S rRNA gene in these species is 99.6% identical. 146
Combining sequences corresponding to these species masks a biological pattern that is readily 147 apparent when considering the unique sequences. sequence was identified that was specific to each species. To avoid analysis of spurious sequences, 154
we limited our analysis to the 500 most abundant unique sequences, which accounted for 71% of 155 the approximately 70 million curated sequencing reads. Using this approach we determined that 156 both the RPS and inulin significantly altered the overall structure of the community (PERMANOVA, 157 p=0.001 and p=0.002, respectively), while the accessible starch and RMS did not (p=1.0 and 158 p=0.65, respectively). None of the supplements significantly changed the alpha diversity, as 159 measured by the inverse Simpson index (p>0.05). 160 161
The Most Affected Bacterial Populations 162
The sequences that changed the most were identified by the ratio of their relative abundance 163 during supplementation to their relative abundance before ( Fig. 2) . Most of the sequences that 164 significantly increased in relative abundance were from species already known to degrade 165 resistant polysaccharides. RPS increased the relative abudance of B. faecale/adolescentis/stercoris 166 sequences 6.5-fold (p<0.001), but there were no significant changes in any of the other sequences 167 classified in the genus Bifidobacterium (Fig. 2) . RMS resulted in a 2.5-fold increase in the relative 168 abundance of sequences classified as R. bromii (p<0.001), but no significant changes in any of 169 those classified as Bifidobacterium (Fig. 2 , Supplemental Table 2 ). Inulin significantly increased the 170 Page 9 of 31 relative abundance of each of the four most abundant sequences assigned to a Bifidobacterium 171 species (Fig. 2 , all p<0.05) and sequences classified as Anaerostipes hadrus (Fig. 2 , Supplemental 172 Table 3 ). No bacterial populations significantly changed in response to the accessible starch 173 supplement ( Fig. 2 , Supplemental Table 4 ). 174
175
We also noted increases in sequences that were not significant for the population as a whole, but 176 which were dramatic within a subset of individuals ( Supplementary Table 1 ). RPS increased the 177 relative abundance of R. bromii sequences in a subset of individuals ( Fig. 3A ), but not for the group 178 as whole (p=0.72). One of the most striking increases in a smaller subset was in Seq100, classified 179 as a member of the Clostridium cluster IV within the family Ruminococcaceae. Clostridium leptum 180 is the closest cultured relative, but their 16S rRNA V4 regions are only 95% identical. This 181
Clostridium leptum-related sequence was detected in 11 of the 50 individuals who consumed RPS, 182 increasing by an average of 10-fold and exceeding 10% relative abundance in several individuals 183 ( Fig. 3A ). Another unanticipated increase was in Seq176 whose V4 region is 98.8% identical to 184 Clostridium chartatabidum, a rumen isolate shown to degrade a variety of dietary fibers (33, 34). 185
It was rarely detected before supplementation, but its relative abundance increased up to 4% 186 relative abundance in 11 of the individuals consuming RPS (Fig. 3A) . Although a large fold change 187
for Seq176 was observed in the accessible starch and Hi-Maize groups ( Fig 3A) , it was limited to 188 one individual in each group. Seq176 reached only 0.03% and 0.14% relative abundance in those 189 two individuals after starting below the limit of detection. 190
Associations between Butyrate Changes and Community Changes 192
In individuals consuming RPS, increases in the relative abundance of sequences attributed to 193 either R. bromii or C. charatabidum were each associated with an increase in butyrate (p=0.025 194 and p=0.0024, Fig. 3B ). On average, there was a 9.1 mmol/kg increase in fecal butyrate when 195 either R. bromii or C. charatabidum sequences increased in relative abundance in response to RPS. 196 There was a decrease of 2.1 mmol/kg in individuals in whom neither sequence increased ( Fig. 3C) . baseline abundance of C. charatabidum was not associated with a butyrate response because it 202 was below the limit of detection (<0.008% abundance) in all but five individuals prior to 203 supplementation. With greater sequencing depth or a more sensitive assay it may be possible to 204 use the presence of these two organisms to predict whether an individual will respond to RPS with 205 increased butyrate. Increases in either B. faecalis/adolescentis/stercoris or Clostridium leptum-like 206 Seq100 were not associated with an increase in butyrate ( Fig. 3B) . 207 208
Partnerships Converting Polysaccharides to Butyrate 209
Increasing R. bromii was associated with higher butyrate levels, but butyrate is not a major end 210 product of R. bromii metabolism (35). Therefore, an increase in R. bromii is not sufficient in itself 211 to explain the association with higher butyrate concentrations. Based on our working model (Fig. 212 Page 11 of 31 1), we expected the increase in primary degraders to lead to an increase in the abundance of 213 butyrate producers (though to a lesser extent because the primary degraders were presumed to 214 extract most of the nutritional value of the supplements for themselves). To test this expectation, 215
we correlated the change in abundance of sequences associated with each of the putative primary 216 degraders with changes in the abundance of the most common known butyrate producers in our 217 cohort ( Fig. 4) . Consistent with our model, change in R. bromii sequences was positively 218 correlated with the change in abundance of E. rectale sequences (Fig 4) . This observation is also 219 consistent with previous reports that populations of R. bromii and E. rectale are associated with 220 each other, both physically and metabolically (22, 24). The relative abundance of E. rectale was 221 also correlated with the concentration of butyrate in the RPS group (Spearman rho=0.42, p<0.001, 222 We tested the effects of fermentable fiber supplements on the structure and function of bacterial 226 communities in the human colon. The three supplements we studied include fractions that are 227 resistant to degradation by host enzymes and therefore pass through the small intestine to the 228 colon. There they can be metabolized by specialized bacteria (which distinguishes them from 229 "bulking fibers" that promote regularity but pass through both small and large intestines without 230 degradation). Two of the supplements we tested were Type 2 Resistant Starches: unmodified 231 starches extracted from potato tubers (RPS) or hi-amylose maize seeds (RMS). However, they had 232 not been pre-treated with -amylase so they included some accessible starch. Only 50%-70% of 233 such flours is in the crystalline form that is resistant to mammalian -amylase (23); the rest is 234 "sensitive" or "accessible" to host enzymes. As a negative control we therefore included a maize Page 12 of 31 starch that is completely digestible by human -amylase so it should be broken down in the small 236 intestine and not affect colonic communities. It was added at a low dose (equivalent to the 237 sensitive portion of the RMS) or a high dose (equivalent to all the glucose monomers in that 238 resistant supplement). In neither case did this placebo produce any statistically significant changes 239 in the microbiota composition or SCFA production during consumption. The third supplement was 240 the fructose polymer, inulin, that is entirely resistant to digestion in the small intestine. 241
242
Consuming resistant RPS led to an increase in the average concentration of fecal butyrate (Table  243 1). Neither inulin nor RMS produced a significant change in butyrate. An important caveat is that 244 the amount of amylose-resistant polysaccharide consumed was not equal across treatment 245 groups. The inulin and Hi-Maize groups consumed approximately 20 and 20-24 grams, 246 respectively, while the RPS group consumed approximately 28-34 grams. However based on 247 preliminary data, the discrepancy is not sufficient to explain the lack of a butyrogenic effect from 248 inulin and Hi-Maize. In a pilot study, we observed a significant increase in fecal butyrate in 249 individuals consuming half the dose of RPS (24 g total, 14-17 g resistant; data not shown). The 250 butyrogenic response to RPS appears due to the nature of the supplement, not just the amount of 251 RS it contains. So the answer to our first research question is that the fiber supplements are not 252 equally effective at stimulating levels of this health-promoting metabolite. 253 254 All the fermentable fiber supplements had some effect on the fecal community (Fig. 2) . In 255 individuals consuming RPS, the largest and most common change in V4 sequences was an increase 256 in sequences attributed to B. faecale/adolescentis/stercoris. This contrasts with an earlier study of 257 dietary supplementation with resistant starch Type 3, where R. bromii was the dominant 258 Page 13 of 31 responder (22, 36) and was therefore proposed to be a keystone species for the degradation of 259 resistant starch (18) . The different responses in our study could be due to differences in the 260 supplements, as has been observed previously when Type 2 or Type 4 resistant starches are 261 consumed (37). The higher abundance of bifidobacteria in our study is consistent with the known 262 ability of B. adolescentis to degrade and ferment RPS in vitro (20), but the increase was not 263 associated with a change in fecal butyrate (Fig. 3B ), suggesting that these organisms are not 264 effectively cross-feeding butyrate producers in vivo -even though they can in vitro (20, 28, 29). It 265 is conceivable that in vivo production of butyrate from such cross-feeding requires additional time 266 for interactions to be established in the gut microbiome. Longer-term studies are currently 267 underway to assess this possibility. The microbiomes in a subset of individuals consuming RPS did 268 respond with an increase in R. bromii-associated sequences. In this group there was an associated 269 increase in fecal concentrations of butyrate so R. bromii may be considered a keystone degrader 270 with regard to butyrate production in our cohort (Fig. 3B ). The major fermentation products of R. 271 bromii are acetate, H 2 and CO 2 , but not butyrate (35) so there must be cross-feeding of a 272 butyrogenic microbe. The most likely candidate is Eubacterium rectale because its abundance 273 increased most consistently with that of R. bromii (Fig. 4) . Two less-well characterized bacterial 274 populations also increased in relative abundance in a few individuals consuming RPS. The increase 275 in the Clostridium leptum-related Seq100 was not associated with an increase in butyrate (Fig. 3B) , 276
suggesting that it too may be a degrader but not a cross-feeder. The Seq176 increase was 277 associated with a butyrate increase (Fig. 3B ), which may be because it is both a degrader and a 278 butyrate producer. The activity of its cultured relative Clostridium chartatabidum against RPS is 279 not documented, but it is a rumen bacterium capable of degrading a variety of plant fibers and, it 280 produces butyrate (33, 34). Attempts to culture the human strain are underway. 281 Individuals consuming RMS did not respond with an increase in the abundance of B. 283 faecale/adolescentis/stercoris sequences. With this supplement, like previous studies (36), an 284 increase in R. bromii-associated sequences was the most common response (Fig. 2) . Unlike the 285 RPS-induced R. bromii increase, the increase in R. bromii on RMS was not associated with a 286 significant increase in fecal butyrate. The lack of a butyrogenic response to RMS was unexpected 287 because the supplement has led to increased fecal butyrate in animal models, though over four 288 weeks (12). We speculate that the crystal structures of the resistant starches from the two plants 289 are different because the RPS is phosphorylated (once every 200 glycosyl residues (38)). They may 290 therefore be degraded with different efficiency or by different strains. Consequently more time 291 may be required to develop cross-feeding interactions that generate measurable differences in 292 fecal butyrate. 293 294 Inulin increased the relative abundance of four species of Bifidobacterium, consistent with the 295 widespread occurrence of this degradative capability within the genus (26) . There were also 296 increases in the abundance of the butyrate producers Anaerostipes hadrus and E. rectale (Fig. 2) , 297 but they did not result in increased fecal butyrate. The A. hadrus may be feeding on the lactate 298 and acetate produced by the more abundant Bifidobacteria on this supplement (31, 32) or it may 299 be able to metabolize inulin itself. We note that the low pKa of lactic acid (pKA = 3.86) produced 300 by the Bifid shunt (30) could reduce fecal pH and inhibit butyrogenic microbes that are sensitive to 301 the lower pH. Subsequent utilization of lactic acid would restore pH but may extend the time 302 required to see an effect. Or it could alter the distribution of microbial populations in the GI tract 303 such that the balance of butyrate consumption and excretion by the host is affected (39). It may 304
Page 15 of 31 also be that lactate produced by Bifidobacterium species was converted to fermentation products 305 other than butyrate. Notably propionate increased by 27% on average with inulin consumption, 306 though the change was not statistically significant due to high variability. Other than 307
Bifidobacterium spp. and A. hadrus, there were no significant increases in any other sequences 308 ( Supplementary Table 3 ), surprisingly including F. prausnitzii (which has the metabolic capacity to 309 ferment inulin to butyrate (27)). 310
311
Thus we observed that all the fermentable fiber supplements we tested increased the relative 312 abundances of some members of the fecal microbiota. Most of the affected sequences are 313 associated with known degraders of resistant polysaccharides or producers of butyrate but we did 314 uncover two Firmicutes not previously associated with fiber supplements. The organisms 315 responding depended both on the individual and the supplement (research question 2). 316 317 Together our observations on SCFA and community composition changes suggest that the working 318 model for stimulating butyrate production with fiber supplements (Fig. 1) is an over-simplification, 319 in that fiber degradation does not always lead to butyrate production. The requirement for fiber 320 breakdown by specialized primary degraders appears to hold, with lack of an appropriate degrader 321 preventing butyrate increase. However, not all degraders lead to a butyrogenic response. The lack 322 of enhanced butyrate production in Bifidobacterium-responding microbiomes suggests that while 323 bifidobacteria are particularly effective at using some fiber supplements, they do not establish 324 cross-feeding reactions with butyrogenic populations as readily as Ruminococcus-responsive 325 microbiomes. Furthermore, the concept of a wide variety of butyrate-producing organisms having 326 ready access to the products of degradation and fermentation is not supported. Even though many 327 Page 16 of 31 of these organisms can be cross-fed by primary degraders in vitro (20, 22, 28, 29) , the in vivo 328 scenario seems much more restricted. The only butyrate producer whose abundance increased 329 with a primary degrader ( Fig. 4) and was associated with higher fecal butyrate (Fig. 5) 
This organism has a multi-protein, cell-wall attached system for degrading sensitive starch (40). It 331 includes carbohydrate binding domains that enable it to attach to RS granules (but not degrade 332 them), as well as ABC transporter proteins that capture oligosaccharide degradation products of 333 the same size as those preferred for growth of R. bromii (22) . It has been shown to co-localize 334 with R. bromii on starch granules (24) and to grow on the products of RS degradation by R. bromii 335 in vitro (22) . It thus has the characteristics of a preferred partner in converting RPS to butyrate 336 (research question 3). A single organism, such as C. chartatabidum, may be an alternative route, 337 but it occurs in fewer individuals. If the C. chartatabidum-related organism from this cohort is 338 indeed a primary degrader of RPS that produces butyrate, it would be an appealing probiotic to 339 give in combination with RPS to enhance butyrate production in a larger percentage of individuals. 340
341
To improve the efficacy of dietary supplements like these, it may be necessary to personalize them 342 according to an individual's gut microbiota (41). The presence of R. bromii or C. chartatabidum 343 suggests whether a gut microbiome would yield increased butyrate concentrations following 344 short-term (2-week) supplementation with RPS (research question 4). Individuals without R. bromii 345 in their gut microbiome may benefit from a probiotic supplementation with R. bromii to increase 346 the likelihood of a butyrogenic response to RPS. There may also be a synergistic effect of 347 combining RPS with both R. bromii and E. rectale to maximize the butyrogenic effect of the 348 supplement. In contrast, microbiomes with high levels of bifidobacteria are less likely to increase 349 butyrate production in response to RPS (or inulin), at least in the short term. In these 350 Page 17 of 31 microbiomes, a different supplement or combination of supplements may be needed, or a longer 351 period of time may be required for the microbiome to respond to the supplement. Such excluded from the study, as were individuals who had taken antibiotics within the last 6 months. 361
Pre-or probiotic usage was not an exclusion criterion for the study. Nor was the amount of fiber 362 already being consumed. All participants gave written, informed consent prior to participating in 363 the study. Participants under the age of 18 were granted permission by a parent or legal guardian. 364
Participants ranged in age from 17 to 29, with a median age of 19. This study was approved by the 365 Institutional Review Board of the University of Michigan Medical School (HUM00094242 and 366 HUM00118951) and was conducted in compliance with the Helsinki Declaration. 367
368
The participants were randomly assigned to study groups. During the first semester they were 369 blinded to the supplement they were taking; in subsequent studies they were informed of its 370 identity. Researchers analyzing samples were always blinded to the supplement associated with 371 the samples. Some participants were excluded from the analysis because fewer than three 372 samples were collected or successfully analyzed either before or during dietary supplementation. at 20 g/day to provide a similar amount of resistant polysaccharide. The accessible starch 397 supplement was given at either 40 g/day (n=15) to provide a similar amount of total carbohydrates 398 or at 20 g/day (n=24) to provide approximately the same amount of host-accessible 399 carbohydrates. Consumption of the supplements was split into two half doses per day and logged 400 on the study website. Participants were provided with a shaker bottle to aid in mixing the 401 supplement with water, however they were permitted to consume the supplement with any type 402 of food or beverage. Participants were instructed not to add the supplement to any warm food or 403 beverage. Aside from the supplement, participants maintained their normal diet throughout the 404 study. The V4 region of the bacterial 16S rRNA gene was amplified and sequenced as described 437 previously using 2 x 250 base pair paired end kits on the Illumina MiSeq sequencing platform (43). 438 Samples were assigned randomly to different runs each semester, with 8 separate DNA 439 sequencing runs in total. Sequences were curated using the mothur software package as described 440 previously (43, 44). Briefly, paired end reads were merged into contigs, screened for sequencing 441 errors, and aligned to the SILVA bacterial SSU reference database. Aligned sequences were 442 screened for chimeras and classified using the Ribosomal Database Project database. Sequences 443 classified as mitochondria, chloroplasts, or archaea were removed. Sequences of interest were 444 further identified using BLAST to align against the 16S rRNA gene sequences database. Unless 445 stated otherwise, species designations indicate 100% identity to a single species in the database. 446
The number of sequences per sample was rarified to 3000 to prevent biases from uneven 447 sampling. yielding a single average community structure for each individual before and during 460 supplementation. Organisms that increased the most in response to each supplement were 461 identified using one-tailed paired Wilcoxon-tests on the average abundances in each subject 462 before and during supplementation with Benjamini-Hochberg correction for multiple comparisons 463 (45). P-values in Figure 2 were corrected for the multiple tests applied to those 14 species, which 464 were a priori expected to important for fiber degradation and/or butyrate production, while p-465 Page 22 of 31 values in Supplemental Tables 1-4 were corrected for test across all 500 sequences. Correlation 466 between the changes in abundance of primary degraders and butyrate producers (Fig. 4) 
